GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sinocare Inc (SZSE:300298) » Definitions » Operating Cash Flow per Share

Sinocare (SZSE:300298) Operating Cash Flow per Share : ¥1.18 (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Sinocare Operating Cash Flow per Share?

Sinocare's operating cash flow per share for the three months ended in Mar. 2024 was ¥-0.06. Sinocare's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.18.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sinocare was -13.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 13.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 15.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 17.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Sinocare's Operating Cash Flow per Share or its related term are showing as below:

SZSE:300298' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -9   Med: 14.3   Max: 48.9
Current: 13.5

During the past 13 years, Sinocare's highest 3-Year average Operating Cash Flow per Share Growth Rate was 48.90% per year. The lowest was -9.00% per year. And the median was 14.30% per year.

SZSE:300298's 3-Year OCF Growth Rate is ranked better than
66.08% of 687 companies
in the Medical Devices & Instruments industry
Industry Median: 2.5 vs SZSE:300298: 13.50

Sinocare Operating Cash Flow per Share Historical Data

The historical data trend for Sinocare's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocare Operating Cash Flow per Share Chart

Sinocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 0.90 0.86 1.22 1.32

Sinocare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.37 0.28 0.59 -0.06

Competitive Comparison of Sinocare's Operating Cash Flow per Share

For the Medical Devices subindustry, Sinocare's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinocare's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sinocare's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sinocare's Price-to-Operating-Cash-Flow falls into.



Sinocare Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Sinocare's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=735.146/556.879
=1.32

Sinocare's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )=Cash Flow from Operations (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=-31.618/555.508
=-0.06

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocare Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Sinocare's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocare (SZSE:300298) Business Description

Traded in Other Exchanges
N/A
Address
No.265 Guyuan Road, Hi-tech Zone, Hunan Province, Changsha, CHN, 410205
Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.
Executives
Li Shao Bo Directors, executives
Che Hong Jing Director
Wang Shi Min Executives
Huang An Guo Directors, executives
Directors, executives
Pan Shu Guang Securities Affairs Representative
Zhou Qing Hua Supervisors
Ning Gui Chun Supervisors
Wang Rui Securities Affairs Representative
Chen Ji Dong Supervisors
Che Hong Li Directors, executives
Zhang Fan Director

Sinocare (SZSE:300298) Headlines

No Headlines